Article

Survival Trends in Waldenström Macroglobulinemia and Comparison of Outcomes with the General US Population

2026-06-17

Abstract excerpt

<title>Abstract</title> <p>Therapeutic options for Waldenström macroglobulinemia (WM) have expanded but improvements in overall-survival (OS) are difficult to interpret due to competing non–WM mortality. We conducted a large single-center retrospective study of 1,020 patients with WM to evaluate survival trends. Patients were stratified by era of active WM diagnosis using a two-era model (1996–2005 and post-2005)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a7422f81-f876-5b52-82b9-8a88dfbe9417
DOI: 10.21203/rs.3.rs-9904019/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Survival Trends in Waldenström Macroglobulinemia and Comparison of Outcomes with the General US PopulationDOI 10.21203/rs.3.rs-9904019/v1Read

Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.Semantic proximity Read

Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.Semantic proximity Read

Clinico-pathologic characteristics, patterns of treatment and outcome of newly diagnosed Waldenströms Macroglobulinemia- a single center real world retrospective analysisSemantic proximity Read

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.Semantic proximity Read

Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.Semantic proximity Read

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.Semantic proximity Read

SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.Semantic proximity Read

Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.Semantic proximity Read

Time trends in survival and causes of death in multiple myeloma: a population-based study from GermanySemantic proximity Read

The Evolution and Subtypes of Waldenstrom Macroglobulinemia: Findings from a Multi-omic Analysis of 249 Treatment Naive MYD88L265P Mutated Patients.Semantic proximity Read

Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemiaSemantic proximity Read

Expanded tumor-associated polymorphonuclear Myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activitySemantic proximity Read